http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102277330-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102277330-B1 |
titleOfInvention | Biomarkers for predicting prognosis after immunotherapy of cancer |
abstract | The present invention relates to a biomarker for selecting patients who are expected to develop immune-related adverse events (irAEs) after treatment with an immunotherapy (PD-1/PD-L1). It is expected that life expectancy will be extended by predicting the occurrence of irAEs before using immunotherapy for cancer patients, especially patients with thymoma and non-small cell lung cancer, so that it is possible to decide whether to use immunotherapy for non-small cell lung cancer patients. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023023269-A1 |
priorityDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 991.